Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer
Clinical trial NCT06773156 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06773156
- Sponsor
- Second Affiliated Hospital of Nanchang University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2028-08-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.